Alexander H. Paterson, MD

Articles by Alexander H. Paterson, MD

Docetaxel/Doxorubicin/Cyclophosphamide in the Treatment of Metastatic Breast Cancer

ByJean-marc A. Nabholtz, MD,Michael Smylie, MD,John R. Mackey, MD,Dick Au, MD,Evelyn Sansregret, MD,Daniel Noel, MD,Alexander H. Paterson, MD,Taher Al-tweigeri, MD,Fernad Delorme, MD,Allesandro Riva, MD

August 1st 1997

Preliminary results from phase I trials suggest that the use of docetaxel (Taxotere) and doxorubicin (Adriamycin) is a well tolerated and highly active combination regimen for

Latest Updated Articles

Docetaxel/Doxorubicin/Cyclophosphamide in the Treatment of Metastatic Breast Cancer
Published: August 1st 1997 | Updated:

Alexander H. Paterson, MD

Articles by Alexander H. Paterson, MD

Docetaxel/Doxorubicin/Cyclophosphamide in the Treatment of Metastatic Breast Cancer

Latest Updated Articles

Trending on CancerNetwork

How Will the Continued Success of ADCs in Breast Cancer Be Propelled in the Future?

Trial Assessing Savolitinib/Osimertinib in NSCLC Completes Enrollment

Searching for Synergy in Liver-Dominant Neuroendocrine Tumors

Neoadjuvant Nivolumab/Ipilimumab Shows Superior EFS in Resectable Melanoma

FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC